By designing sgRNAs targeting Ntn1 gene, CLAN successfully disrupted the Ntn1 gene in macrophages and their precursor monocytes in vivo, ameliorating the symptoms of T2D. Here, NTN1 is linked to type 2 diabetes mellitus.